drugset / Trial / NCT03971929
Safety and Effect Study of SHR0532 (Drug Code) Tablets in Patients With Mild Hypertension
RandomizedParallel-groupTriple-blindTreatment
Summary
The study is being conducted to evaluate the safety and efficacy and Pharmacokinetics/Pharmacodynamics of SHR0532 in subjects with mild hypertension for 4 weeks.
Timeline
- Start
- 2019-07-31
- Primary completion
- 2020-09-03
- Completion
- 2020-09-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Hydrochlorothiazide | Unknown | 25 mg | Oral |
| Subject | SHR0532 | Unknown | — | Oral |